Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial.
Abraham WT, Piccini JP, Dufton C, Carroll IA, Healey JS, O'Connor CM, Marshall D, Aleong R, van Veldhuisen DJ, Rienstra M, Wilton SB, White M, Sauer WH, Anand IS, Huebler SP, Connolly SJ, Bristow MR.
Abraham WT, et al. Among authors: healey js.
Heart Rhythm O2. 2021 Nov 14;3(1):40-49. doi: 10.1016/j.hroo.2021.11.005. eCollection 2022 Feb.
Heart Rhythm O2. 2021.
PMID: 35243434
Free PMC article.